Search Results
Results found for "xylazine research"
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Research using techniques like bioluminescence resonance energy transfer (BRET) and fluorescence resonance In summary, dimerization in class B1 GPCRs is an emerging area of research that has far-reaching implications
- Adhesion GPCR Consortium Newsletter - May 2024
Investigación y de Estudios Avanzados del IPN (Cinvestav) How did you become involved in adhesion GPCR research What challenges will researchers overcome in the next 10 years? AB: The next workshop will likely bring together some of the hottest adhesion GPCR research going on
- 📰 GPCR Weekly News
impairs growth of patient-derived xenografts of colorectal carcinoma in mice Methods & Updates in GPCR Research Interactions in the Serotonin 1A Receptor Microenvironment Industry News Addex and Indivior Extend Research
- Pharmacology at Your Fingertips: Terry’s Corner Launches
GPCR partner Celtarys Research has validated a TR-FRET assay for cannabinoid receptor ligands using their
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Dive into a world of knowledge where you can search by topics and events . Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy Methods & Updates in GPCR Research
- 📰 GPCR Weekly News, October 23 to 29, 2023
Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies Methods & Updates in GPCR Research Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research
- A cryptic mode of GPCR regulation revealed
October 2022 "Over three decades of research have provided thorough insights into G protein-coupled receptor
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Hello GPCR friends👋, Stay informed with the latest developments in GPCR research and industry news! Methods & Updates in GPCR Research Illuminating the brain-genetically encoded single wavelength fluorescent on Gliovascular Unit of Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research
- Novo Nordisk moves to strengthen obesity efforts
Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Congress of Basic and Clinical Pharmacology GPCR Jobs HIGHLIGHT Senior Scientist, GPCR Pharmacology Research co-transmission sets the activity pattern in the C. elegans egg-laying circuit Methods & Updates in GPCR Research
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)."
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Recent research has unveiled the emergence of G-protein-independent pathways, particularly those involving By understanding the intricacies of GPCR signaling and utilising advanced assay technologies, researchers
- Tectonic Therapeutic Strengthens Leadership Team
therapies (G-Protein Coupled Receptors), today announced the promotion of Senior Vice President, Head of Research
- Function and structure of bradykinin receptor 2 for drug discovery
review, we summarize the structure and function of B2R in relation to drug discovery and discuss future research
- Molecular insights into psychedelic drug action
desire for additional approaches to mental health care, incremental progress in basic and clinical research
- Molecular targets of psychedelic-induced plasticity
August 2022 "Psychedelic research across different disciplines and biological levels is growing at a
- Neurotransmitters: Potential Targets in Glioblastoma
neurotransmitter receptors have shown great potential for inhibiting GBM growth and development, requiring further research
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
Discovery Experts to Watch (coming soon) In the run-up to the summit, we're speaking with some of the researchers
- 📰 GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of the Gliovascular Unit of Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience with the target and analogizes the search
- Michel Bouvier appointed Knight of the Ordre national du Québec
Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology Research
- Community guidelines for GPCR ligand bias: IUPHAR review 32
The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
Previous research showed that activation of Gq/11 proteins by G-protein coupled receptors has pro-nociceptive
- 📰 GPCR Weekly News, January 8 to 14, 2024
July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Senior Researcher in Structural Biology NEW Post-Doctoral Fellow Postdoctoral Fellow Research Laboratory Specialist Associate
- GPCR Therapeutics Expands Scientific Advisory Board
Jon Wigginton will provide scientific expertise to support the company’s research and clinical development
- Domain Therapeutics Raises $42m Series A Financing
STRASBOURG, France & MONTREAL- Domain Therapeutics, a biopharmaceutical company specializing in the research
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing
- Dr. Adriano Marchese - Dr. GPCR Podcast
Learn about his remarkable career and research in #GPCR signaling and trafficking.







